Risk of breast cancer with HRT depends on therapy type and duration.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 35260385.
- Also identified by DOI 10.1136/bmj.o485.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The studyVinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. <i>BMJ</i> 2020;371:m3873. To read the full NIHR Alert, go to: https://evidence.nihr.ac.uk/alert/risk-of-breast-cancer-with-hrt-depends-therapy-type-and-duration/.
Medical subject headings
- Breast Neoplasms
- Estrogen Replacement Therapy
- Estrogens
- Progestins